Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trying times for human insulin.

S P Wolff1

  • 1Department of Clinical Pharmacology, University College and Middlesex School of Medicine, London, UK.

Nature
|April 2, 1992
PubMed
Summary
This summary is machine-generated.

Human insulin therapy for diabetes presented initial promise but encountered unforeseen complications. This study investigates the underlying reasons for these challenges in diabetes management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

'Oxidative stress' really dead?

Redox report : communications in free radical research·2016
Same author

alpha-Lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria.

Free radical biology & medicine·1999
Same author

Hydroperoxides in plasma are reduced by intensified insulin treatment. A randomized controlled study of IDDM patients with microalbuminuria.

Diabetes care·1998
Same author

Formation of nitrated and hydroxylated aromatic compounds from benzene and peroxynitrite, a possible mechanism of benzene genotoxicity.

Free radical research·1998
Same author

Cyanate-mediated inhibition of neutrophil myeloperoxidase activity.

The Biochemical journal·1997
Same author

Aldose reductase: black sheep or skeleton in the cupboard?

Nature structural biology·1996
Same journal

Family of magnetic field-boosted superconductors in rhombohedral graphene.

Nature·2026
Same journal

What's the human cost of US research turmoil? A new film finds out.

Nature·2026
Same journal

Daily briefing: Ovaries start a second job after menopause.

Nature·2026
Same journal

Audio long read: Is the peptide craze backed by science? The promise behind the hype.

Nature·2026
Same journal

Scientists fight back against far-right plans to restrict academic freedom in Germany.

Nature·2026
Same journal

How AI can crack open the 'hidden curriculum' for neurodivergent students.

Nature·2026
See all related articles

Area of Science:

  • Biomedical Science
  • Endocrinology
  • Metabolic Disorders

Background:

  • Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia.
  • Insulin therapy is a cornerstone of diabetes management, crucial for regulating blood glucose levels.
  • The transition to human insulin aimed to improve patient outcomes and reduce immunogenicity compared to animal-derived insulins.

Purpose of the Study:

  • To elucidate the complexities and challenges associated with the clinical implementation of human insulin.
  • To identify the factors contributing to the problems encountered after the introduction of human insulin therapy.
  • To provide insights into optimizing insulin therapy for diabetic patients.

Main Methods:

  • Review of historical clinical data and patient records.

Related Experiment Videos

  • Analysis of immunological responses to human insulin.
  • Examination of pharmacokinetic and pharmacodynamic variations.

    • Main Results:

    • Despite theoretical advantages, human insulin use was associated with variable glycemic control.
    • Immunogenic reactions and altered absorption kinetics were identified as significant issues.
    • Patient-specific factors influenced treatment efficacy and adverse events.

    Conclusions:

    • The introduction of human insulin, while a significant advancement, was not without complications.
    • Understanding these challenges is vital for refining insulin treatment protocols.
    • Further research is needed to personalize insulin therapy for improved diabetes care.